Oruka Therapeutics (ORKA) Selling, General & Administrative (2009 - 2026)
Oruka Therapeutics' Selling, General & Administrative was $2.99 million in Q2 2024, up 74.1% from $1.72 million a year earlier and up 29.1% from the prior quarter.
Powered by 
Analysis
Oruka Therapeutics (ORKA) Selling, General & Administrative (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Oruka Therapeutics' Selling, General & Administrative was $8.47 million through Jun 30, 2024, up 37.9% year-over-year; for FY2023, it came in at $6.28 million, up 7.5% from FY2022.
- Selling, General & Administrative has now increased for five consecutive years, with a five-year compound annual growth rate of 10.1% (FY2018 to FY2023).
- In earlier years, Selling, General & Administrative was $5.85 million in FY2022 (+6.3%), $5.5 million in FY2021 (+15.3%), $4.77 million in FY2020 (+19.9%) and $3.98 million in FY2019 (+2.6%).
- The Q2 2024 figure marks the highest quarterly Selling, General & Administrative in data going back to Q2 2010.
- Compared with a year earlier, Selling, General & Administrative has increased for four straight quarters, with growth averaging 22.6% over the last eight quarters.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q4 2020 (growth of 115.0%); the worst was Q4 2022 (a decline of 14.5%).
- Per Business Quant data, ORKA's Selling, General & Administrative in the three quarters before Q2 2024 was $2.32 million (Q1 2024), $1.54 million (Q4 2023) and $1.62 million (Q3 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.13 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.09 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.89 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.11 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.68 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.64 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.28 Bn |
| 10 | Oruka Therapeutics | 7.43 Bn | 4.55 Bn | - | 8.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 8.44 Mn |
| Jun 30, 2026 | 6.85 Mn |
| Mar 31, 2026 | 7.29 Mn |
| Dec 31, 2025 | 6.79 Mn |
| Sep 30, 2025 | 5.12 Mn |
| Jun 30, 2025 | 4.34 Mn |
| Mar 31, 2025 | 5.16 Mn |
| Dec 31, 2024 | 4.82 Mn |
| Sep 30, 2024 | 3.76 Mn |
| Jun 30, 2024 | 2.99 Mn |
| Mar 31, 2024 | 2.32 Mn |
| Dec 31, 2023 | 1.54 Mn |
| Sep 30, 2023 | 1.62 Mn |
| Jun 30, 2023 | 1.72 Mn |
| Mar 31, 2023 | 1.41 Mn |
| Dec 31, 2022 | 1.49 Mn |
| Sep 30, 2022 | 1.53 Mn |
| Jun 30, 2022 | 1.73 Mn |
| Mar 31, 2022 | 1.10 Mn |
| Dec 31, 2021 | 1.74 Mn |
API Access
Oruka Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ORKA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ORKA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ORKA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();